跳至主要内容
临床试验/CTRI/2021/01/030199
CTRI/2021/01/030199招募中未知

The effect of continuation versus withholding angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers on mortality and major adverse cardiovascular events in hypertensive patients undergoing elective non-cardiac surgery: An open-label randomised controlled trial - ACE Trial

Dr Satyajeet Misra0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • All hypertensive adult patients, 18-70 years, on chronic ACEI/ARB therapy (defined as treatment of more than 3 months or at least 14 days) and undergoing elective major non-cardiac surgery (defined as surgery lasting more than 2 hours and/or with an expected postoperative hospital stay of at least 3 days) will be included in this trial

排除标准

  • Patients undergoing emergency surgeries within 48 hours, those with preoperative hyperkalemia (serum potassium > 5.5 mmol/L), patients with severe chronic renal insufficiency or those requiring renal replacement therapy, patients in shock (defined as need for vasoactive drugs to maintain blood pressures before surgery), patients taking ACEI/ARBs for LV dysfunction, and patients with uncontrolled hypertension will be excluded.

研究者

发起方
Dr Satyajeet Misra

相似试验

Continuation or stopping antihypertensives in... | 临床试验